8-K: Stablecoin Development Corp Rebrands and Updates SKY Assets

Stablecoin Development Corporation, formerly NovaBay Pharmaceuticals, has officially rebranded and reported holding 2.15 billion SKY tokens.

Summary

• The company has completed its name change from NovaBay Pharmaceuticals, Inc. to Stablecoin Development Corporation.
• Common stock is now trading on the NYSE American under the ticker symbol SDEV.
• As of March 31, 2026, the company holds approximately 2.15 billion SKY tokens, representing 9.15% of the total supply.
• Cumulative staking rewards earned total approximately 35.3 million SKY tokens.
• The company acquired 1.17 billion additional SKY tokens on the open market at an average price of $0.065 per token since January 2026.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral-to-positive update; while the rebranding and asset accumulation show clear execution of the new strategy, the inherent risks of the crypto-asset sector remain high.

Positives

• Successful transition to a new strategic focus on digital asset ecosystems.
• Significant accumulation of SKY tokens, increasing holdings from 2.06 billion to 2.15 billion in two weeks.
• Growth in cumulative staking rewards from 26.6 million to 35.3 million tokens.
• Clear strategic alignment with the Sky protocol ecosystem.

Negatives

• Staking rewards are subject to variability based on protocol governance and participation levels.
• The company is heavily concentrated in a single digital asset (SKY), increasing exposure to protocol-specific risks.

Risks

• High volatility inherent in digital asset markets.
• Regulatory uncertainty regarding digital assets and staking activities.
• Potential for adverse changes in protocol governance parameters.
• Cybersecurity risks associated with holding and staking digital assets.

Future Outlook

The company intends to continue its strategy as an on-chain holding company, focusing on disciplined treasury management, staking participation, and long-term engagement in protocol-aligned digital asset ecosystems.

Management Comments

• We believe our public market identity now more clearly reflects our strategy.
• Our objective is to build a disciplined public vehicle designed to provide public market access to the stablecoin economy.
• We believe this name and ticker better align the Company's market presence with its balance sheet, operating strategy, and capital allocation priorities.

Industry Context

StockSavvy.ai notes that this pivot from a pharmaceutical business to a digital asset holding company mirrors a broader trend of public entities seeking to capture value from decentralized finance (DeFi) protocols, though it introduces significant regulatory and market volatility risks compared to traditional corporate models.

Comparison to Industry Standards

• The company's strategy of holding governance tokens for staking yield is similar to models used by digital asset investment firms like MicroStrategy or various crypto-native holding companies.
• Unlike traditional pharmaceutical companies, the firm's valuation is now tied to the performance and governance of the Sky protocol rather than drug development pipelines.

Corporate Governance

Stakeholder Impact

• Shareholders now have exposure to a digital asset holding company rather than a pharmaceutical business.
• Investors are subject to the risks of the Sky protocol ecosystem.

Next Steps

• Continued participation in Sky protocol governance.
• Ongoing evaluation of opportunities to enhance stockholder exposure to protocol-level economic activity.

Key Dates

Recommendation

The company is in the early stages of a radical business model pivot. While the accumulation of assets is transparent, the long-term viability of the Sky protocol and the regulatory environment for such entities remain highly uncertain, warranting a cautious hold until further operational history is established.

Keywords

SDEV, Stablecoin Development Corporation, SKY token, Staking, Digital assets, NYSE American, Cryptocurrency